Celanese director granted 3.5 phantom stock units

Kissire Deborah J. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Kissire Deborah J. reported acquisition or exercise transactions in this Form 4 filing.

Celanese Corp director Deborah J. Kissire received an automatic award of 3.505 shares of phantom stock tied to deferred compensation dividends. Each phantom stock unit represents the right to receive one share of Celanese common stock under the company’s 2008 Deferred Compensation Plan. Following this grant, she holds a total of 5,924.793 phantom stock units directly, which will eventually be settled in common shares as provided in the plan. This filing reflects routine compensation-related accruals rather than an open-market stock purchase or sale.

Insider Trade Summary

Grant/Award: 3.505 shares

Grant/Award 1 txn

Insider Kissire Deborah J.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock	3.505	$50.67	$177.60

Holdings After Transaction: Phantom Stock — 5,924.793 contracts (Direct)

Footnotes (2)

1. F1. Each share of phantom stock represents the right to receive one share of Common Stock.
2. F2. The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Celanese (CE) report for Deborah J. Kissire?

Celanese reported that director Deborah J. Kissire received 3.505 shares of phantom stock. The grant reflects dividend equivalents credited on deferred compensation and is settled in common stock according to the company’s 2008 Deferred Compensation Plan, not an open-market stock purchase.

What is the size of Deborah J. Kissire’s new phantom stock grant at Celanese (CE)?

Deborah J. Kissire was granted 3.505 shares of phantom stock. These units represent dividend equivalents on deferred compensation and track Celanese common stock value, ultimately payable in shares as outlined in the 2008 Deferred Compensation Plan for participating directors and executives.

How many phantom stock units does Deborah J. Kissire now hold in Celanese (CE)?

After the latest grant, Deborah J. Kissire holds 5,924.793 phantom stock units. Each phantom unit represents the right to receive one share of Celanese common stock, payable in accordance with the company’s 2008 Deferred Compensation Plan governing deferred compensation elections.

Is the Celanese (CE) Form 4 for Deborah J. Kissire a stock purchase or sale?

The Form 4 does not show a market purchase or sale. It reports an acquisition coded as a grant of 3.505 phantom stock units, representing dividend equivalents credited on deferred compensation, which will later be settled in Celanese common shares under the plan’s terms.

What are phantom stock units in the context of Celanese (CE)?

At Celanese, each phantom stock unit represents the right to receive one share of common stock. These units typically mirror the value of Celanese shares and, under the 2008 Deferred Compensation Plan, become payable in common stock at future distribution dates set by plan elections.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/11/2026 - 04:42 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kissire Deborah J.

(Last) (First) (Middle)

C/O CELANESE CORPORATION

222 W LAS COLINAS BLVD, SUITE 900N

(Street)

IRVING TX 75039

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Celanese Corp [ CE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock	(1)	03/10/2026		A		3.505		(2)	(2)	Common Stock	3.505	$50.67	5,924.793	D

Explanation of Responses:

1. Each share of phantom stock represents the right to receive one share of Common Stock.

2. The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan.

Remarks:

	/s/ Christine Dryden, Attorney-in-Fact for Deborah J. Kissire	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.